SCRT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SCRT, covering 2022-09-06 to 2022-09-06. Get the full timeline:
Most recent: Clinical Trial Update: Study of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid Tumors [Phase 2]